Skip to main content
SpringerLink
Log in

Control of CD4+ T Cell Differentiation and Function by PI3K Isoforms

  • Chapter
  • First Online:
PI3K and AKT Isoforms in Immunity

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 436))

  • 865 Accesses

Abstract

The phosphoinositide-3-kinase (PI3K) pathway is a highly conserved intracellular signaling pathway involving numerous key effectors which, in response to diverse extracellular stimuli, modulate the phenotype and function of most mammalian cell types in a pleiotropic manner. PI3K signaling plays a critical role in the development, activation, and differentiation of lymphocytes. In particular, the PI3Kδ and PI3Kγ isoforms have been shown to carry out essential, non-redundant roles in T cells, and therefore, tight regulation of the PI3K pathway is important to maintain the balance between immune tolerance and inflammation. Recent and ongoing efforts to manipulate the biology of T helper cell subsets in the treatment of autoimmune conditions, inflammatory disorders, as well as cancer have shown promising results, and targeting the PI3K pathway may be beneficial in these contexts. However, more insight as to the precise function of individual PI3K isoforms in pathogenic and protective immune cell subsets is still required, and how exactly PI3K signaling is regulated and integrated with classical immune pathways. This chapter provides an overview of the role of PI3K isoforms in the differentiation and function of T helper cell subsets, within the broader context of targeting this pathway to potentially alleviate immunopathology.

B. Cameron and S. A. Zaheer—These authors contributed equally to this manuscript.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Ahmad S, Abu-Eid R, Shrimali R, Webb M, Verma V, Doroodchi A et al (2017) Differential PI3Kdelta signaling in CD4(+) T-cell subsets enables selective targeting of T regulatory cells to enhance cancer immunotherapy. Cancer Res 77(8):1892–1904

    Article  CAS  PubMed  Google Scholar 

  • Alcazar I, Marques M, Kumar A, Hirsch E, Wymann M, Carrera AC et al (2007) Phosphoinositide 3-kinase gamma participates in T cell receptor-induced T cell activation. J Exp Med 204(12):2977–2987

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Aragoneses-Fenoll L, Montes-Casado M, Ojeda G, Acosta YY, Herranz J, Martinez S et al (2016) ETP-46321, a dual p110alpha/delta class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis. Biochem Pharmacol 106:56–69

    Article  CAS  PubMed  Google Scholar 

  • Aragoneses-Fenoll L, Ojeda G, Montes-Casado M, Acosta-Ampudia Y, Dianzani U, Portoles P et al (2018) T-cell-specific loss of the PI-3-kinase p110alpha catalytic subunit results in enhanced cytokine production and antitumor response. Front Immunol 9:332

    Article  PubMed  PubMed Central  Google Scholar 

  • Avery DT, Kane A, Nguyen T, Lau A, Nguyen A, Lenthall H et al (2018) Germline-activating mutations in PIK3CD compromise B cell development and function. J Exp Med 215(8):2073–2095

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Azzi J, Moore RF, Elyaman W, Mounayar M, El Haddad N, Yang S et al (2012) The novel therapeutic effect of phosphoinositide 3-kinase-gamma inhibitor AS605240 in autoimmune diabetes. Diabetes 61(6):1509–1518

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Berod L, Heinemann C, Heink S, Escher A, Stadelmann C, Drube S et al (2011) PI3Kgamma deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcome. Eur J Immunol 41(3):833–844

    Article  CAS  PubMed  Google Scholar 

  • Bhaumik S, Basu R (2017) Cellular and molecular dynamics of Th17 differentiation and its developmental plasticity in the intestinal immune response. Front Immunol 8:254

    Article  PubMed  PubMed Central  Google Scholar 

  • Bi E, Ma X, Lu Y, Yang M, Wang Q, Xue G et al (2017) Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of TH9 cells programmed by IL-7. Sci Sig 10(500)

    Google Scholar 

  • Bier J, Rao G, Payne K, Brigden H, French E, Pelham SJ et al (2019) Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4(+) T cells. J Allergy Clin Immunol 144(1):236–253

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Binne LL, Scott ML, Rennert PD (2007) Human TIM-1 associates with the TCR complex and up-regulates T cell activation signals. J Immunol 178(7):4342–4350

    Article  CAS  PubMed  Google Scholar 

  • Blanco B, Herrero-Sanchez MC, Rodriguez-Serrano C, Sanchez-Barba M, Del Canizo MC (2015) Profound blockade of T cell activation requires concomitant inhibition of different class I PI3K isoforms. Immunol Res 62(2):175–188

    Article  CAS  PubMed  Google Scholar 

  • Brembilla NC, Senra L, Boehncke WH (2018) The IL-17 family of cytokines in psoriasis: IL-17A and beyond. Front Immunol 9:1682

    Article  PubMed  PubMed Central  Google Scholar 

  • Buttrick TS, Wang W, Yung C, Trieu KG, Patel K, Khoury SJ et al (2018) Foxo1 promotes Th9 cell differentiation and airway allergy. Sci Rep 8(1):818

    Article  PubMed  PubMed Central  Google Scholar 

  • Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, Shaw J et al (2005) Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11(9):936–943

    Article  CAS  PubMed  Google Scholar 

  • Capone A, Volpe E (2020) Transcriptional regulators of T helper 17 cell differentiation in health and autoimmune diseases. Front Immunol 11:348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen H, Zhang L, Wang P, Su H, Wang W, Chu Z et al (2017) mTORC2 controls Th9 polarization and allergic airway inflammation. Allergy 72(10):1510–1520

    Article  CAS  PubMed  Google Scholar 

  • Chen X, Guo Y, Han R, Liu H, Ding Y, Shi Y et al (2018) Class I PI3K inhibitor ZSTK474 attenuates experimental autoimmune neuritis by decreasing the frequency of Th1/Th17 cells and reducing the production of proinflammatory cytokines. Cell Immunol 329:41–49

    Article  CAS  PubMed  Google Scholar 

  • Chornoguz O, Hagan RS, Haile A, Arwood ML, Gamper CJ, Banerjee A et al (2017) mTORC1 promotes T-bet phosphorylation to regulate Th1 differentiation. J Immunol 198(10):3939–3948

    Article  CAS  PubMed  Google Scholar 

  • Comerford I, Litchfield W, Kara E, McColl SR (2012) PI3Kgamma drives priming and survival of autoreactive CD4(+) T cells during experimental autoimmune encephalomyelitis. PLoS ONE 7(9):e45095

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cook KD, Miller J (2010) TCR-dependent translational control of GATA-3 enhances Th2 differentiation. J Immunol 185(6):3209–3216

    Article  CAS  PubMed  Google Scholar 

  • Courtney AH, Lo WL, Weiss A (2018) TCR signaling: mechanisms of initiation and propagation. Trends Biochem Sci 43(2):108–123

    Article  CAS  PubMed  Google Scholar 

  • Croft M, So T, Duan W, Soroosh P (2009) The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev 229(1):173–191

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y et al (2011) Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146(5):772–784

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dardalhon V, Korn T, Kuchroo VK, Anderson AC (2008) Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 31(3):252–256

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Deane JA, Fruman DA (2004) Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol 22:563–598

    Article  CAS  PubMed  Google Scholar 

  • DeFrances MC, Debelius DR, Cheng J, Kane LP (2012) Inhibition of T-cell activation by PIK3IP1. Eur J Immunol 42(10):2754–2759

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, Xiao B et al (2009) The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30(6):832–844

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR et al (2011) The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol 12(4):295–303

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dornan GL, Siempelkamp BD, Jenkins ML, Vadas O, Lucas CL, Burke JE (2017) Conformational disruption of PI3Kdelta regulation by immunodeficiency mutations in PIK3CD and PIK3R1. Proc Natl Acad Sci U S A 114(8):1982–1987

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Di Fonte R, Baronio M, Plebani A, Lougaris V, Fousteri G (2016) Reduced germinal center follicular helper T cells but normal follicular regulatory T cells in the tonsils of a patient with a mutation in the PI3KR1 gene. Clin Immunol 164:43–44

    Article  PubMed  Google Scholar 

  • Del Prete A, Vermi W, Dander E, Otero K, Barberis L, Luini W et al (2004) Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. EMBO J 23(17):3505–3515

    Article  PubMed  PubMed Central  Google Scholar 

  • Elkaim E, Neven B, Bruneau J, Mitsui-Sekinaka K, Stanislas A, Heurtier L, et al (2016) Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase delta syndrome 2: a cohort study. J Allergy Clin Immunol 138(1):210-8 e9

    Google Scholar 

  • Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, Plas DR et al (2002) The CD28 signaling pathway regulates glucose metabolism. Immunity 16(6):769–777

    Article  CAS  PubMed  Google Scholar 

  • Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M (2004) PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30(2):193–204

    Article  PubMed  Google Scholar 

  • Fruman DA, Bismuth G (2009) Fine tuning the immune response with PI3K. Immunol Rev 228(1):253–272

    Article  CAS  PubMed  Google Scholar 

  • Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT (2017) The PI3K pathway in human disease. Cell 170(4):605–635

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gerriets VA, Rathmell JC (2012) Metabolic pathways in T cell fate and function. Trends Immunol 33(4):168–173

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ghigo A, Damilano F, Braccini L, Hirsch E (2010) PI3K inhibition in inflammation: toward tailored therapies for specific diseases. BioEssays 32(3):185–196

    Article  CAS  PubMed  Google Scholar 

  • Goto F, Uchiyama T, Nakazawa Y, Imai K, Kawai T, Onodera M (2017) Persistent impairment of T-cell regeneration in a patient with activated PI3K delta syndrome. J Clin Immunol 37(4):347–350

    Article  CAS  PubMed  Google Scholar 

  • Han JM, Patterson SJ, Levings MK (2012) The role of the PI3K signaling pathway in CD4(+) T cell differentiation and function. Front Immunol 3:245

    Article  PubMed  PubMed Central  Google Scholar 

  • Hawkins PT, Stephens LR (2015) PI3K signalling in inflammation. Biochim Biophys Acta 1851(6):882–897

    Article  CAS  PubMed  Google Scholar 

  • Hawkins PT, Anderson KE, Davidson K, Stephens LR (2006) Signalling through Class I PI3Ks in mammalian cells. Biochem Soc Trans 34(Pt 5):647–662

    Article  CAS  PubMed  Google Scholar 

  • Hawse WF, Sheehan RP, Miskov-Zivanov N, Menk AV, Kane LP, Faeder JR et al (2015) Cutting edge: differential regulation of PTEN by TCR, Akt, and FoxO1 controls CD4+ T cell fate decisions. J Immunol 194(10):4615–4619

    Article  CAS  PubMed  Google Scholar 

  • Haylock-Jacobs S, Comerford I, Bunting M, Kara E, Townley S, Klingler-Hoffmann M et al (2011) PI3Kdelta drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. J Autoimmun 36(3–4):278–287

    Article  CAS  PubMed  Google Scholar 

  • He Y, Dong L, Cao Y, Bi Y, Liu G (2020) IL-9 and Th9 cells in tumor immunity. Adv Exp Med Biol 1240:35–46

    Article  CAS  PubMed  Google Scholar 

  • Heikamp EB, Patel CH, Collins S, Waickman A, Oh MH, Sun IH et al (2014) The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex. Nat Immunol 15(5):457–464

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hermann-Kleiter N, Baier G (2010) NFAT pulls the strings during CD4+ T helper cell effector functions. Blood 115(15):2989–2997

    Article  CAS  PubMed  Google Scholar 

  • Hoshino A, Tanaka Y, Akiba H, Asakura Y, Mita Y, Sakurai T et al (2003) Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma. Eur J Immunol 33(4):861–869

    Article  CAS  PubMed  Google Scholar 

  • Hu S, Wang R, Zhang M, Liu K, Tao J, Tai Y et al (2019) BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway. Biomed Pharmacother 114:108796

    Article  CAS  PubMed  Google Scholar 

  • Huang H, Long L, Zhou P, Chapman NM, Chi H (2020) mTOR signaling at the crossroads of environmental signals and T-cell fate decisions. Immunol Rev 295(1):15–38

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jacobs SR, Herman CE, Maciver NJ, Wofford JA, Wieman HL, Hammen JJ et al (2008) Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol 180(7):4476–4486

    Article  CAS  PubMed  Google Scholar 

  • Jenner RG, Townsend MJ, Jackson I, Sun K, Bouwman RD, Young RA et al (2009) The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes. Proc Natl Acad Sci U S A 106(42):17876–17881

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jia L, Wu C (2014) Differentiation, regulation and function of Th9 cells. Adv Exp Med Biol 841:181–207

    Article  CAS  PubMed  Google Scholar 

  • Kane LP, Weiss A (2003) The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol Rev 192:7–20

    Article  CAS  PubMed  Google Scholar 

  • Kaplan MH (2013) Th9 cells: differentiation and disease. Immunol Rev 252(1):104–115

    Article  PubMed  PubMed Central  Google Scholar 

  • Kerdiles YM, Beisner DR, Tinoco R, Dejean AS, Castrillon DH, DePinho RA et al (2009) Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol 10(2):176–184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kok K, Nock GE, Verrall EA, Mitchell MP, Hommes DW, Peppelenbosch MP et al (2009) Regulation of p110delta PI 3-kinase gene expression. PLoS ONE 4(4):e5145

    Article  PubMed  PubMed Central  Google Scholar 

  • Koyasu S (2003) The role of PI3K in immune cells. Nat Immunol 4(4):313–319

    Article  CAS  PubMed  Google Scholar 

  • Kuhlen M, Honscheid A, Loizou L, Nabhani S, Fischer U, Stepensky P et al (2016) De novo PIK3R1 gain-of-function with recurrent sinopulmonary infections, long-lasting chronic CMV-lymphadenitis and microcephaly. Clin Immunol 162:27–30

    Article  CAS  PubMed  Google Scholar 

  • Kurebayashi Y, Nagai S, Ikejiri A, Ohtani M, Ichiyama K, Baba Y et al (2012) PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORgamma. Cell Rep 1(4):360–373

    Article  CAS  PubMed  Google Scholar 

  • Laine A, Martin B, Luka M, Mir L, Auffray C, Lucas B et al (2015) Foxo1 Is a T cell-intrinsic inhibitor of the RORgammat-Th17 program. J Immunol 195(4):1791–1803

    Article  CAS  PubMed  Google Scholar 

  • Lee K, Gudapati P, Dragovic S, Spencer C, Joyce S, Killeen N et al (2010) Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 32(6):743–753

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li J, Chen S, Xiao X, Zhao Y, Ding W, Li XC (2017) IL-9 and Th9 cells in health and diseases—from tolerance to immunopathology. Cytokine Growth Factor Rev 37:47–55

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Licona-Limon P, Arias-Rojas A, Olguin-Martinez E (2017) IL-9 and Th9 in parasite immunity. Semin Immunopathol 39(1):29–38

    Article  CAS  PubMed  Google Scholar 

  • Lin L, Hron JD, Peng SL (2004) Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21(2):203–213

    Article  CAS  PubMed  Google Scholar 

  • Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U et al (2014) Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency. Nat Immunol 15(1):88–97

    Article  CAS  PubMed  Google Scholar 

  • Lucas CL, Chandra A, Nejentsev S, Condliffe AM, Okkenhaug K (2016) PI3Kdelta and primary immunodeficiencies. Nat Rev Immunol 16(11):702–714

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Luo CT, Li MO (2018) Foxo transcription factors in T cell biology and tumor immunity. Semin Cancer Biol 50:13–20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Malik S, Awasthi A (2018) Transcriptional control of Th9 cells: role of Foxo1 in interleukin-9 induction. Front Immunol 9:995

    Article  PubMed  PubMed Central  Google Scholar 

  • Malik S, Sadhu S, Elesela S, Pandey RP, Chawla AS, Sharma D et al (2017) Transcription factor Foxo1 is essential for IL-9 induction in T helper cells. Nat Commun 8(1):815

    Article  PubMed  PubMed Central  Google Scholar 

  • Michalovich D, Nejentsev S (2018) Activated PI3 kinase delta syndrome: from genetics to therapy. Front Immunol 9:369

    Article  PubMed  PubMed Central  Google Scholar 

  • Miller AT, Wilcox HM, Lai Z, Berg LJ (2004) Signaling through Itk promotes T helper 2 differentiation via negative regulation of T-bet. Immunity 21(1):67–80

    Article  CAS  PubMed  Google Scholar 

  • Nagai S, Kurebayashi Y, Koyasu S (2013) Role of PI3K/Akt and mTOR complexes in Th17 cell differentiation. Ann N Y Acad Sci 1280:30–34

    Article  CAS  PubMed  Google Scholar 

  • Nakayama T, Hirahara K, Onodera A, Endo Y, Hosokawa H, Shinoda K et al (2017) Th2 cells in health and disease. Annu Rev Immunol 35:53–84

    Article  CAS  PubMed  Google Scholar 

  • Nashed BF, Zhang T, Al-Alwan M, Srinivasan G, Halayko AJ, Okkenhaug K et al (2007) Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation. Eur J Immunol 37(2):416–424

    Article  CAS  PubMed  Google Scholar 

  • Oh H, Ghosh S (2013) NF-kappaB: roles and regulation in different CD4(+) T-cell subsets. Immunol Rev 252(1):41–51

    Article  PubMed  PubMed Central  Google Scholar 

  • Okano T, Imai K, Tsujita Y, Mitsuiki N, Yoshida K, Kamae C et al (2019) Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase delta syndrome type 1. J Allergy Clin Immunol 143(1):266–275

    Article  CAS  PubMed  Google Scholar 

  • Okkenhaug K (2013) Signaling by the phosphoinositide 3-kinase family in immune cells. Annu Rev Immunol 31:675–704

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Okkenhaug K, Vanhaesebroeck B (2003) PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol 3(4):317–330

    Article  CAS  PubMed  Google Scholar 

  • Okkenhaug K, Patton DT, Bilancio A, Garcon F, Rowan WC, Vanhaesebroeck B (2006) The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. J Immunol 177(8):5122–5128

    Article  CAS  PubMed  Google Scholar 

  • Peng M, Yin N, Chhangawala S, Xu K, Leslie CS, Li MO (2016) Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science 354(6311):481–484

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pinto MES, Licona-Limon P (2017) Th9 cells and parasitic inflammation: use of Nippostrongylus and Schistosoma models. Methods Mol Biol 1585:223–245

    Article  PubMed  Google Scholar 

  • Pompura SL, Dominguez-Villar M (2018) The PI3K/AKT signaling pathway in regulatory T-cell development, stability, and function. J Leukoc Biol

    Google Scholar 

  • Powell JD, Delgoffe GM (2010) The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 33(3):301–311

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Preite S, Cannons JL, Radtke AJ, Vujkovic-Cvijin I, Gomez-Rodriguez J, Volpi S et al (2018) Hyperactivated PI3Kdelta promotes self and commensal reactivity at the expense of optimal humoral immunity. Nat Immunol 19(9):986–1000

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Preite S, Gomez-Rodriguez J, Cannons JL, Schwartzberg PL (2019) T and B-cell signaling in activated PI3K delta syndrome: from immunodeficiency to autoimmunity. Immunol Rev 291(1):154–173

    Article  CAS  PubMed  Google Scholar 

  • Rao VK, Webster S, Dalm V, Sediva A, van Hagen PM, Holland S et al (2017) Effective “activated PI3Kdelta syndrome”-targeted therapy with the PI3Kdelta inhibitor leniolisib. Blood 130(21):2307–2316

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Roller A, Perino A, Dapavo P, Soro E, Okkenhaug K, Hirsch E et al (2012) Blockade of phosphatidylinositol 3-kinase PI3Kdelta or PI3Kgamma reduces IL-17 and ameliorates imiquimod-induced psoriasis-like dermatitis. J Immunol 189(9):4612–4620

    Article  CAS  PubMed  Google Scholar 

  • Ruterbusch M, Pruner KB, Shehata L, Pepper M (2020) In vivo CD4(+) T cell differentiation and function: revisiting the Th1/Th2 paradigm. Annu Rev Immunol 38:705–725

    Article  CAS  PubMed  Google Scholar 

  • Saleiro D, Platanias LC (2015) Intersection of mTOR and STAT signaling in immunity. Trends Immunol 36(1):21–29

    Article  CAS  PubMed  Google Scholar 

  • Salmond RJ (2018) mTOR regulation of glycolytic metabolism in T cells. Front Cell Dev Biol 6:122

    Article  PubMed  PubMed Central  Google Scholar 

  • Saravia J, Chapman NM, Chi H (2019) Helper T cell differentiation. Cell Mol Immunol 16(7):634–643

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schwartzberg PL, Finkelstein LD, Readinger JA (2005) TEC-family kinases: regulators of T-helper-cell differentiation. Nat Rev Immunol 5(4):284–295

    Article  CAS  PubMed  Google Scholar 

  • So L, Fruman DA (2012) PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances. Biochem J 442(3):465–481

    Article  CAS  PubMed  Google Scholar 

  • Sogkas G, Fedchenko M, Dhingra A, Jablonka A, Schmidt RE, Atschekzei F (2018) Primary immunodeficiency disorder caused by phosphoinositide 3-kinase delta deficiency. J Allergy Clin Immunol 142(5):1650-3 e2

    Google Scholar 

  • Soond DR, Bjorgo E, Moltu K, Dale VQ, Patton DT, Torgersen KM et al (2010) PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans. Blood 115(11):2203–2213

    Article  CAS  PubMed  Google Scholar 

  • Stark AK, Sriskantharajah S, Hessel EM, Okkenhaug K (2015) PI3K inhibitors in inflammation, autoimmunity and cancer. Curr Opin Pharmacol 23:82–91

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stark JM, Tibbitt CA, Coquet JM (2019) The metabolic requirements of Th2 cell differentiation. Front Immunol 10:2318

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Swat W, Montgrain V, Doggett TA, Douangpanya J, Puri K, Vermi W et al (2006) Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival. Blood 107(6):2415–2422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Takeda M, Ito W, Tanabe M, Ueki S, Kihara J, Kato H et al (2010) The pathophysiological roles of PI3Ks and therapeutic potential of selective inhibitors in allergic inflammation. Int Arch Allergy Immunol 152(Suppl 1):90–95

    Article  CAS  PubMed  Google Scholar 

  • Tesmer LA, Lundy SK, Sarkar S, Fox DA (2008) Th17 cells in human disease. Immunol Rev 223:87–113

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Uche UU, Piccirillo AR, Kataoka S, Grebinoski SJ, D’Cruz LM, Kane LP (2018) PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt. J Exp Med 215(12):3165–3179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vanhaesebroeck B, Ali K, Bilancio A, Geering B, Foukas LC (2005) Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem Sci 30(4):194–204

    Article  CAS  PubMed  Google Scholar 

  • Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 11(5):329–341

    Article  CAS  PubMed  Google Scholar 

  • Vanhaesebroeck B, Whitehead MA, Pineiro R (2016) Molecules in medicine mini-review: isoforms of PI3K in biology and disease. J Mol Med (berl) 94(1):5–11

    Article  CAS  Google Scholar 

  • Vogt PK, Hart JR, Gymnopoulos M, Jiang H, Kang S, Bader AG et al (2010) Phosphatidylinositol 3-kinase: the oncoprotein. Curr Top Microbiol Immunol 347:79–104

    CAS  PubMed  Google Scholar 

  • Wang X, Ding J, Meng LH (2015) PI3K isoform-selective inhibitors: next-generation targeted cancer therapies. Acta Pharmacol Sin 36(10):1170–1176

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang P, Zhang Q, Tan L, Xu Y, Xie X, Zhao Y (2020) The regulatory effects of mTOR complexes in the differentiation and function of CD4(+) T cell subsets. J Immunol Res 2020:3406032

    Article  PubMed  PubMed Central  Google Scholar 

  • Way EE, Trevejo-Nunez G, Kane LP, Steiner BH, Puri KD, Kolls JK et al (2016) Dose-dependent suppression of cytokine production from T cells by a novel phosphoinositide 3-kinase delta inhibitor. Sci Rep 6:30384

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wilke CM, Bishop K, Fox D, Zou W (2011) Deciphering the role of Th17 cells in human disease. Trends Immunol 32(12):603–611

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Winkler DG, Faia KL, DiNitto JP, Ali JA, White KF, Brophy EE et al (2013) PI3K-delta and PI3K-gamma inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models. Chem Biol 20(11):1364–1374

    Article  CAS  PubMed  Google Scholar 

  • Wymann M (2012) PI3Ks-drug targets in inflammation and cancer. Subcell Biochem 58:111–181

    Article  CAS  PubMed  Google Scholar 

  • Yuan HX, Guan KL (2015) The SIN1-PH domain connects mTORC2 to PI3K. Cancer Discov 5(11):1127–1129

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang Y, Zhang Y, Gu W, Sun B (2014) TH1/TH2 cell differentiation and molecular signals. Adv Exp Med Biol 841:15–44

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Imperial College London, London, W2 1PG, UK

    Benjamin Cameron, Syed Aymaan Zaheer & Margarita Dominguez-Villar

Authors
  1. Benjamin Cameron
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Syed Aymaan Zaheer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Margarita Dominguez-Villar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Margarita Dominguez-Villar .

Editor information

Editors and Affiliations

  1. Faculty of Medicine, Imperial College London, London, UK

    Margarita Dominguez-Villar

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cameron, B., Zaheer, S.A., Dominguez-Villar, M. (2022). Control of CD4+ T Cell Differentiation and Function by PI3K Isoforms. In: Dominguez-Villar, M. (eds) PI3K and AKT Isoforms in Immunity . Current Topics in Microbiology and Immunology, vol 436. Springer, Cham. https://doi.org/10.1007/978-3-031-06566-8_8

Download citation

Publish with us

Policies and ethics

Search

Navigation